Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in China
723 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in ChinaEfficacy and Safety of AK112 Combined Chemotherapy as Neoadjuvant Treatment for Signet Ring Cell-containing G/GEJ Adenocarcinoma
- Where
- Beijing
- Age
- 18 years to 75 years
- People
- 66
- Run by
- Peking Union Medical College Hospital
See details and how to joinNCT07091227 - No phaseTaking peopleDeep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
- Where
- Wuhan
- Age
- 18 years and over
- People
- 300
- Run by
- Tongji Hospital
See details and how to joinNCT07088354 - No phaseNot yet taking people in ChinaComparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD
- Where
- Chengdu, Nanning, Shanghai, Shenyang
- Age
- 18 years to 80 years
- People
- 169
- Run by
- Changhai Hospital
See details and how to joinNCT07088744 - No phaseTaking peopleAn Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
- Where
- Chongqing
- Age
- 70 years and over
- People
- 40
- Run by
- Three Gorges Hospital of Chongqing University
See details and how to joinNCT07080437 - No phaseTaking peopleApplication of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study
- Where
- Shanghai
- Age
- 18 years to 80 years
- People
- 52
- Run by
- Huashan Hospital
See details and how to joinNCT06679244 - No phaseTaking peopleDevelopment and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer:MetBio-GC
- Where
- Shanghai
- Age
- 18 years and over
- People
- 250
- Run by
- Shanghai Minimally Invasive Surgery Center
See details and how to joinNCT07076979 - Phase 3Taking peopleTislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Fuzhou
- Age
- 18 years to 70 years
- People
- 269
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT06793917 - Phase 1/2Taking peopleFruquintinib in Combination With Sintilimab and CAPEOX as First-line Treatment for G/GEJ Cancer
- Where
- Zhengzhou
- Age
- 18 years to 75 years
- People
- 70
- Run by
- Henan Cancer Hospital
See details and how to joinNCT06329973 - No phaseTaking peopleThe Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
- Where
- Changzhi
- Age
- 18 years to 75 years
- People
- 170
- Run by
- Changzhi People's Hospital Affiliated to Changzhi Medical College
See details and how to joinNCT07069842 - Phase 2Taking peopleJS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma
- Where
- Guangzhou
- Age
- 18 years to 75 years
- People
- 43
- Run by
- Sun Yat-sen University
See details and how to joinNCT05173246 - No phaseTaking peopleClinical Evaluation of GRAPE Model for Gastric Cancer Screening
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 1,000,000
- Run by
- Zhejiang Cancer Hospital
See details and how to joinNCT07067983 - Phase 3Not yet taking people in ChinaPerioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer
- Where
- Hangzhou
- Age
- 18 years to 80 years
- People
- 470
- Run by
- Xiangdong Cheng
See details and how to joinNCT07068516 - Phase 3Taking peopleNeoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma
- Where
- Lanzhou
- Age
- 18 years to 75 years
- People
- 668
- Run by
- Zuoyi Jiao
See details and how to joinNCT06949033 - Phase 1Taking peopleA Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
- Where
- Hefei
- Age
- 18 years to 75 years
- People
- 20
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06232083 - Phase 1Taking peoplePhase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
- Where
- Tianjin
- Age
- 18 years and over
- People
- 80
- Run by
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773507 - No phaseTaking peopleEfficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 30
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07056010 - No phaseTaking peoplePatient Derived Organoids (PDOs) to Observe the Clinical Consistency of Personalized Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma
- Where
- Shanghai
- Age
- 18 years to 75 years
- People
- 30
- Run by
- Shanghai Zhongshan Hospital
See details and how to joinNCT07054086 - No phaseTaking peopleA Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies Screening
- Where
- Guangzhou
- Age
- 45 years and over
- People
- 10,000
- Run by
- Nanfang Hospital, Southern Medical University
See details and how to joinNCT07032961 - Phase 2Not yet taking people in ChinaOmega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 80
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT07050524 - Phase 1/2Taking peopleClinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Where
- Shanghai
- Age
- 18 years to 70 years
- People
- 40
- Run by
- Shanghai Public Health Clinical Center
See details and how to joinNCT03093688 - No phaseEnrolling by invitationExplainable Machine Learning for Predicting Early Gastric Cancer
- Where
- Wenzhou
- People
- 10
- Run by
- Wenzhou Central Hospital
See details and how to joinNCT07047937 - Phase 2Taking peopleRobotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy
- Where
- Nanjing
- Age
- 18 years to 80 years
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06895447 - No phaseTaking peopleComparison of Endoscopy and Esophagram for the Routine Evaluation of Anastomosis After McKeown Esophagectomy
- Where
- Guangzhou
- Age
- 18 years and over
- People
- 2
- Run by
- Sun Yat-sen University
See details and how to joinNCT07043491 - No phaseTaking peopleThe Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
- Where
- Hangzhou, Jinan, Nanchang, Nanjing, Shanghai, Tianjin, Xi’an
- Age
- 18 years to 60 years
- People
- 1,200
- Run by
- RenJi Hospital
See details and how to joinNCT06081647 - Phase 1Taking peopleHS-10502 Combination Treatment in Patients With Advanced Solid Tumors
- Where
- Shanghai
- Age
- 18 years and over
- People
- 157
- Run by
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT06769425